Colistin for the treatment of urinary tract infections caused by extremely drug-resistant Pseudomonas aeruginosa: a call for a dose update

OBJECTIVES: Optimal dosage regimens of colistin for the treatment of urinary tract infections (UTI) are unknown. Colistimethate sodium (CMS), the inactive prodrug of colistin, is mainly excreted in urine and converts to colistin after filtration by glomeruli, suggesting that concentrations of colist...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Infect
Autori principali: Sorlí, Luisa, Luque, Sonia, Li, Jian, Campillo, Núria, Danés, Marc, Montero, Milagro, Segura, Concha, Grau, Santiago, Horcajada, Juan Pablo
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2019
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7265153/
https://ncbi.nlm.nih.gov/pubmed/31265867
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jinf.2019.06.011
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi